Plain-English translation of NCT05257551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study invites people with advanced small cell lung cancer to participate in careful tracking of their disease. Researchers will collect tumor tissue samples and blood samples at different points during your standard cancer treatment to study genetic markers that may help predict how your cancer responds to therapy and progresses over time.
Small cell lung cancer is a fast-growing form of lung cancer, and doctors need better ways to understand and predict how it will respond to treatment. By studying tumor and blood samples from patients receiving standard care, researchers hope to discover patterns that could improve future treatment decisions.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue receiving your regular cancer treatment as planned. The study involves providing tumor tissue samples (either before your first treatment starts or at a later visit if your doctor recommends a re-biopsy) and donating blood samples at various points during your treatment. Researchers will track these samples and your disease progression over time as you receive first-line and possibly second-line chemotherapy, with no additional treatment given specifically for the study.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States